It will be a slow ride but it will take you there. Has gone past resistance at 3 and now moving in the right direction. Has 45mill in cash and it has no competition.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%